Presentation TCT 2013

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Presenter: Peter Smits, A. J. van Boven, Mariano Valdes, Antonio Serra, Jean-Jacques Goy, V. Voudris, Ramiro Trillo, J. M. Vazquez, Peter den Heijer, Ton Slagboom, A.G. Vuillomenet

January 31, 2013

REGISTER for free or LOG IN to view this content

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

DES/BRS/DCB

Presentation

TCT 2013

Up Next

Presentation TCT 2013

Validation of Transapical Access Accuracy of Computed Tomographic Angiography-Fluoroscopy Fusion Guided Structural Heart Disease Interventions

Presenter: Bryce Einhorn

January 31, 2013

Chronic Total Occlusion Lesion Revascularization Alone versus Complete Revascularization in Chronic Total Occlusion Patients with Multivessel Disease

Presenter: Seung-Woon Rha

January 31, 2013

Presentation TCT 2013

High Level of Copeptin in ST elevation Acute Myocardial Infarction patients is associated with In-Hospital Mortality and Plaque Rupture; TAMI-COP study

Presenter: Sang-Wook Kim

January 31, 2013

Advertisement

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

REGISTER for free or LOG IN to view this content

Up Next

Validation of Transapical Access Accuracy of Computed Tomographic Angiography-Fluoroscopy Fusion Guided Structural Heart Disease Interventions

Chronic Total Occlusion Lesion Revascularization Alone versus Complete Revascularization in Chronic Total Occlusion Patients with Multivessel Disease

High Level of Copeptin in ST elevation Acute Myocardial Infarction patients is associated with In-Hospital Mortality and Plaque Rupture; TAMI-COP study

Advertisement

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

REGISTER for free or LOG IN to view this content

Up Next

We Recommend

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...